While transcriptional heterogeneity at the single cell level and longitudinal alterations in the bulk epigenomes of IDH mutant gliomas have been investigated, little is known about intratumoral epigenetic heterogeneity at the single cell level [16, 39, 43]. The gene discussed is IDH2; the disease is central nervous system cancer.